SciELO - Scientific Electronic Library Online

 
vol.24 issue1Incidence of congenital malformations of the central nervous system in newborns in Chiapas, Mexico, and associated factorsAssociation of anemia with Parkinson’s disease: a systematic review with meta-analysis of epidemiological studies author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista mexicana de neurociencia

On-line version ISSN 2604-6180Print version ISSN 1665-5044

Abstract

ANAYA-ESCAMILLA, Antonio; MARTINEZ-BRAVO, Luis E.  and  JIMENEZ-CASTILLO, Gilberto A.. COVID-19 and diabetes mellitus in cognitive impairment: an undrawn relationship. Rev. mex. neurocienc. [online]. 2023, vol.24, n.1, pp.13-18.  Epub Jan 25, 2023. ISSN 2604-6180.  https://doi.org/10.24875/rmn.22000039.

Cognitive impairment is a potential short- and long-term disease consequence of COVID-19 virus, the exact mechanism is still in debate. One of their potential linking is with diabetes. Diabetes and COVID-19 infection have possible multiple common mechanisms that could ensue cognitive impairment as pulmonary microthrombi (silent hypoxia); endothelial dysfunction; cerebral vascular injury oxidative stress; renin-angiotensin-aldosterone system; and galectine and interferon responses. In addition, histological markers as amyloid AB plaques and neurofibrillary tangle of Tau protein are common in both pathologies. Despite of this evidence, diabetes mellitus and COVID-19 in cognitive impairment are establishing a bright light in terms of neurological progress. This article describes the relationship between diabetes mellitus and COVID-19 as potential cause of cognitive impairment.

Keywords : COVID-19; Diabetes mellitus; Cognitive dysfunction; Inflammation; Amyloid.

        · abstract in Spanish     · text in English